Scott T. Rottinghaus serves as Executive at ENANTA PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Scott T. Rottinghaus has executed 13 insider transactions totaling $207.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 5, 2025 involved selling 798 shares valued at $11.4K.
Scott T. Rottinghaus currently holds 21,792 shares of ENANTA PHARMACEUTICALS INC (ENTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott T. Rottinghaus has been a net seller of ENTA stock. They have purchased $0 and sold $207.2K worth of shares.
Scott T. Rottinghaus's most recent insider trade was on Dec 5, 2025, when they sold 798 shares at $14.23 per share.
Get notified when new Form 4 filings are submitted
| $6.99 |
| Discretionary |
| Aug 8, 2024 | ENTA | $18.7K | Payment | 1,466 | $12.73 | Discretionary |
| Jul 15, 2024 | ENTA | $48.3K | Option Exercise | 5,375 | $8.99 | Planned |
| Jul 15, 2024 | ENTA | $91.8K | Sale | 5,375 | $17.08 | Planned |
| Jul 12, 2024 | ENTA | $34.2K | Sale | 2,271 | $15.04 | Planned |
| Jul 11, 2024 | ENTA | $64.8K | Sale | 4,299 | $15.07 | Planned |
| Feb 12, 2024 | ENTA | $0 | Award | 2,576 | $N/A | Discretionary |
| Feb 12, 2024 | ENTA | $9.4K | Payment | 755 | $12.41 | Discretionary |
| Dec 5, 2023 | ENTA | $5.1K | Sale | 534 | $9.63 | Discretionary |
| Aug 8, 2023 | ENTA | $25.3K | Payment | 1,467 | $17.23 | Discretionary |
| Nov 23, 2022 | ENTA | $0 | Award | 7,000 | $N/A | Discretionary |
| Aug 8, 2022 | ENTA | $0 | Award | 20,000 | $N/A | Discretionary |